Diaceutics (LON:DXRX) Shares Down 4.4% – Here’s Why

Diaceutics PLC (LON:DXRX) shares were down 4.4% during mid-day trading on Friday . The stock traded as low as GBX 150 and last traded at GBX 151. Approximately 74,272 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 139,853 shares. The stock had previously closed at GBX 158.

Diaceutics Stock Performance

The company has a market cap of £127.78 million, a PE ratio of -83.89 and a beta of 0.58. The company has a debt-to-equity ratio of 0.39, a quick ratio of 9.92 and a current ratio of 4.85. The stock’s 50-day simple moving average is GBX 161.87 and its 200 day simple moving average is GBX 142.08.

Diaceutics (LON:DXRX) last issued its quarterly earnings results on Tuesday, September 23rd. The company reported GBX (2.84) earnings per share (EPS) for the quarter. Diaceutics had a negative return on equity of 7.15% and a negative net margin of 10.90%. As a group, equities analysts anticipate that Diaceutics PLC will post 1.0107919 EPS for the current year.

About Diaceutics

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.